2017 Top 500 Market Capitalization of Chinese Listed Companies | 42 Pharmaceutical Companies List

Pharmaceutical Network January 18 hearing recently, the East Wealth Network released the "2017 Top 500 Chinese listed companies market value list," of which 42 pharmaceutical companies list.

As of the closing date of the stock market in 2017 (December 29), the total market value of Chinese companies listed in the world ranking finalized in the list of pharmaceutical companies, Hengrui medicine has become the absolute 'leader', Kang US medicine Industry, Fosun medicine , The market value of Yunnanbaiyao also exceeded 100 billion mark.And in a wave of favorable policies and market warming, the pharmaceutical stocks but menacing.

Pharmaceutical stocks for many stocks or not stocks, it seems no stranger to each and every time the market is in a weak cycle, the plate can always bring us some surprises, especially vulnerable to the underprivileged Baotuan warm varieties.

It is understood that the medical bio-segment performance from the late September 2017 quite satisfactory, the latest cumulative increase of about 5% plate.

Insiders said that the market value of the company's share price rose significantly this year.Hengrui medicine so far rose more than 70%, Fosun Pharma rose more than 81%, and Zhi-Fei biological, Ireland Eye, Pien Tze Huang and other market cap gains are also obvious .

Obviously, the pharmaceutical companies in China have drawn more and more attention from the investment market, and on the other hand, we can see that while everyone is saying that the market environment for competition is grim and the pharmaceutical companies are struggling, many enterprise In fact, already quietly muffled big fortune.

In a good market, the medical people, how much did you make this year?

Attachment: 2017 Chinese listed companies market value 500 list of pharmaceutical companies